SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Opko Health, Inc. – ‘10-K’ for 12/31/09

On:  Wednesday, 3/17/10, at 5:28pm ET   ·   For:  12/31/09   ·   Accession #:  950123-10-25641   ·   File #:  1-33528

Previous ‘10-K’:  ‘10-K’ on 3/16/09 for 12/31/08   ·   Next:  ‘10-K/A’ on 11/10/10 for 12/31/09   ·   Latest:  ‘10-K’ on 3/1/24 for 12/31/23   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/17/10  Opko Health, Inc.                 10-K       12/31/09    9:1.1M                                   Donnelley … Solutions/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    729K 
 2: EX-10.24    Material Contract                                   HTML    116K 
 3: EX-10.25    Material Contract                                   HTML    146K 
 4: EX-21       Subsidiaries                                        HTML      6K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML      7K 
 6: EX-31.1     Certification -- Sarbanes-Oxley Act - Sect. 302     HTML     13K 
 7: EX-31.2     Certification -- Sarbanes-Oxley Act - Sect. 302     HTML     13K 
 8: EX-32.1     Certification -- Sarbanes-Oxley Act - Sect. 906     HTML      8K 
 9: EX-32.2     Certification -- Sarbanes-Oxley Act - Sect. 906     HTML      8K 




        
Filing Submission 0000950123-10-025641 – SGML Text

Original SGML Text submitted by:  Donnelley Financial Solutions/FA  (as Filing Agent) 

Show all <DOCUMENT> <TEXT> elements below – 1.1M                        Top    Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20100317-174908	 Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20100317-174908	 Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20100317-172813	 Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0000950123-10-025641
<TYPE>				10-K
<PUBLIC-DOCUMENT-COUNT>		10
<PERIOD>			20091231
<FILING-DATE>			20100317
<DATE-OF-FILING-DATE-CHANGE>	20100317
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		Opko Health, Inc.
<CIK>				0000944809
<ASSIGNED-SIC>			3841
<IRS-NUMBER>			752402409  75-2402409
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			10-K
<ACT>				34
<FILE-NUMBER>			001-33528
<FILM-NUMBER>			10689627
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			4400 BISCAYNE BLVD.
<STREET2>			SUITE 900
<CITY>				MIAMI
<STATE>				FL
<ZIP>				33137
<PHONE>				305-575-6015
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			4400 BISCAYNE BLVD.
<STREET2>			SUITE 900
<CITY>				MIAMI
<STATE>				FL
<ZIP>				33137
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		eXegenics Inc
<DATE-CHANGED>			20040505
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		EXEGENICS INC
<DATE-CHANGED>			20011114
</FORMER-COMPANY>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		CYTOCLONAL PHARMACEUTICS INC /DE
<DATE-CHANGED>			19950503
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>		10-K
<SEQUENCE>	1
<FILENAME>	g22453e10vk.htm
<DESCRIPTION>	FORM 10-K
<TEXT>
<HTML>
       Show <HTML>: 20,307 lines (widest: 240 characters) - 844K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-10.24
<SEQUENCE>	2
<FILENAME>	g22453exv10w24.htm
<DESCRIPTION>	EX-10.24
<TEXT>
<HTML>
       Show <HTML>: 1,958 lines (widest: 216 characters) - 111K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-10.25
<SEQUENCE>	3
<FILENAME>	g22453exv10w25.htm
<DESCRIPTION>	EX-10.25
<TEXT>
<HTML>
       Show <HTML>: 3,353 lines (widest: 261 characters) - 176K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-21
<SEQUENCE>	4
<FILENAME>	g22453exv21.htm
<DESCRIPTION>	EX-21
<TEXT>
<HTML>
       Show <HTML>: 80 lines (widest: 110 characters) - 3K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-23.1
<SEQUENCE>	5
<FILENAME>	g22453exv23w1.htm
<DESCRIPTION>	EX-23.1
<TEXT>
<HTML>
       Show <HTML>: 34 lines (widest: 147 characters) - 2K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-31.1
<SEQUENCE>	6
<FILENAME>	g22453exv31w1.htm
<DESCRIPTION>	EX-31.1
<TEXT>
<HTML>
       Show <HTML>: 201 lines (widest: 100 characters) - 8K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-31.2
<SEQUENCE>	7
<FILENAME>	g22453exv31w2.htm
<DESCRIPTION>	EX-31.2
<TEXT>
<HTML>
       Show <HTML>: 199 lines (widest: 100 characters) - 8K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-32.1
<SEQUENCE>	8
<FILENAME>	g22453exv32w1.htm
<DESCRIPTION>	EX-32.1
<TEXT>
<HTML>
       Show <HTML>: 96 lines (widest: 193 characters) - 4K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		EX-32.2
<SEQUENCE>	9
<FILENAME>	g22453exv32w2.htm
<DESCRIPTION>	EX-32.2
<TEXT>
<HTML>
       Show <HTML>: 85 lines (widest: 193 characters) - 3K bytes  
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>		GRAPHIC
<SEQUENCE>	10  Not a Document/Exhibit
<FILENAME>	g22453g22453e01.gif
<DESCRIPTION>	GRAPHIC
<TEXT>
       Show <TEXT>: 456 lines (Unix-to-Unix encoding) - 28K bytes  
</TEXT>
</DOCUMENT>
</SUBMISSION>
Top

Filing Submission 0000950123-10-025641   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 3:57:12.4pm ET